Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample

American Journal on Addictions

Volumn 24, Issue 7, 2015, Pages 586-589

  Medhus, Sigrid ^a,b   Rognli, Eline Borger ^a,c,d   Gossop, Michael ^a,e   Holm, Bjørn ^b   Mørland, Jørg ^f   Bramness, Jørgen G ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b LOVISENBERG DIAKONALE HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders   (Norway)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DELUSIONAL DISORDER; FEMALE; FOLLOW UP; HOMELESSNESS; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD REVIEW; METHAMPHETAMINE-INDUCED PSYCHOSIS; MORTALITY; PARANOID SCHIZOPHRENIA; PROSPECTIVE STUDY; RISK FACTOR; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; DISEASE COURSE; NORWAY; PSYCHOSES, SUBSTANCE-INDUCED;

AMPHETAMINE; DISEASE PROGRESSION; HUMANS; NORWAY; PROSPECTIVE STUDIES; PSYCHOSES, SUBSTANCE-INDUCED; RISK FACTORS; SCHIZOPHRENIA;

EID: 84942549716     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12274     Document Type: Article

References (10)

1. Caton CLM, Hasin D, Shrout PE, et al., Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Br J Psychiatry. 2007; 190: 105 -111.
2. Niemi-Pynttäri J, Sund R, Putkonen H, et al., Substance-induced psychoses converting into schizophrenia: A register-based study of 18,478 Finnish inpatient cases. J Clin Psychiatry. 2013; 74: e94-e99.
3. Kittirattanapaiboon P, Mahatnirunkul S, Booncharoen H, et al., Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug Alcohol Rev. 2010; 29: 456-461.
4. Medhus S, Mordal J, Holm B, et al., A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards. Psychiatry Res. 2012; 206: 17-21.
5. Fazel S, Khosla V, Doll H, et al., The prevalence of mental disorders among the homeless in western countries: Systematic review and meta-regression analysis. PLoS Medicine. 2008; 5: e225.
6. Rognli EB, Hakansson A, Berge J, et al., Does the pattern of amphetamine use prior to incarceration predict later psychosis?-A longitudinal study of amphetamine users in the Swedish criminal justice system. Drug Alcohol Dep. 2014.
7. Curran C, Byrappa N, Mcbride A,. Stimulant psychosis: Systematic review. Br J Psychiatry. 2004; 185: 196-204.
8. Caton CLM, Drake RE, Hasin DS, et al., Differences Between Early-Phase Primary Psychotic Disorders With Concurrent Substance Use and Substance-Induced Psychoses. Arch Gen Psychiatry. 2005; 62.
9. Parks J, Svendsen D, Singer P, et al., Morbidity and mortality in people with serious mental illness. National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council Alexandria, VA; 2006.
10. Kuo CJ, Liao YT, Chen WJ, et al., Causes of death of patients with methamphetamine dependence: A record-linkage study. Drug Alcohol Rev. 2011; 30: 621-628.